Diabeloop: Launch of a Multi-Country Clinical Study in Adolescents and Young Adults With T1D
23 févr. 2023 02h00 HE | Diabeloop SA
BERLIN, Feb. 23, 2023 (GLOBE NEWSWIRE) -- At the International Conference on Advanced Technologies & Treatments for Diabetes, Diabeloop, a leader in Automated Insulin Delivery technology,...
logo-alt.png
Drug Eluting Stent Market is estimated to be US$ 14.02 billion by 2032 with a CAGR of 6.5% during the forecast period 2032 - By PMI
19 oct. 2022 09h03 HE | PMI
Covina, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Drug Eluting Stent Market accounted for US$ 7.5 billion in 2022 and is estimated to be US$ 14.02 billion by 2032 and is anticipated to register a CAGR of...
AID system based on DBLG1 and MEDISAFE WITH, Patient wearing MEDISAFE WITH
Terumo Corporation and Diabeloop SA Enter Into Comprehensive Strategic Partnership Agreement to Expand Their Diabetes Care Offerings
17 nov. 2021 19h00 HE | Diabeloop SA
TOKYO & PARIS, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Terumo Corporation, a global leader in medical technology, and the French company Diabeloop, a pioneer in therapeutic AI, announced today that...